BELGIAN SOCIETY OF CARDIOLOGY

⏰Do not miss early bird rate - Register now 👉 https://lnkd.in/eApqnTAx Make sure to register by 16 Dec. to benefit from the early bird rate. 🧾Programme 👉 https://lnkd.in/eAyy3CHv 📆Dates : 6-7 Feb. 2025 📌Location : Brussels Expo

✨ 25 ESC free registrations will be distributed to young cardiologists during the BSC congress, based on the following criteria: ▶️ Be under 40 or in training ▶️ Be a BSC Member - Not yet member? Apply (free for juniors) 👉 https://lnkd.in/eXdmShew ▶️ Be an ESC Professional Member What do you need to do? ▶️ Register for the BSC Congress: 6-7 Feb. 2025, at Brussels Expo 👉 https://lnkd.in/eApqnTAx ▶️ Visit the BSC Booth on Friday 7 Feb., at the entrance of the congress centre. Free registrations will be assigned on a first-come, first-served basis. Don't miss out on this opportunity! 📆 Mark your calendar for the ESC Congress: 29 Aug. to 1 Sept. 2025, in Madrid. Not a young cardiologist yourself? Share the message with your trainees!

Valvular heart disease (VHD) and pulmonary hypertension (PH) are significant cardiovascular disorders with distinct yet sometimes overlapping pathophysiologies. VHD results from structural or functional valve abnormalities caused by degenerative processes, rheumatic disease, congenital defects, or endocarditis, leading to altered hemodynamics and heart failure. PH, defined as a mean pulmonary arterial pressure ≥20 mmHg, arises from diverse causes, including left heart disease, chronic lung disease, or idiopathic mechanisms, and can occur independently or secondary to VHD. Advances in diagnostics, including echocardiography and pulmonary hemodynamic indices like the pulmonary artery pulsatility index (PAPi), have enhanced the assessment and stratification of both conditions. Innovative therapies for PH, such as sotatercept, target vascular remodelling and complement expanding interventional options for VHD. A thorough understanding of these conditions’ interplay is essential to optimising management and improving outcomes in these complex cardiovascular disorders. 👉 Continue reading https://lnkd.in/eXg8Dk5Y An editorial from Patrizio Lancellotti & Raluca Dulgheru 👇 ACTA subscription is included in the BSC membership 🤗 Not yet a member? Apply 👉 https://lnkd.in/eXdmShew and discover the many other benefits.

Do not miss the 32rd Annual Symposium of The Young Cardiologists’ Club (YCC)👇

⏰Do not miss early bird rate - Register now 👉https://lnkd.in/eApqnTAx Make sure to register by 16 Dec. to benefit from the early bird rate. 🧾Programme 👉https://lnkd.in/eAyy3CHv 📆Dates : 6-7 Feb. 2025 📌Location : Brussels Expo 👇A sneak peek at our lineup👇

Heart failure (HF) continues to represent a pivotal focus in cardiology research and innovation due to its multifaceted pathophysiology and its association with substantial morbidity and mortality. Recent progress in HF management encompasses advancements in pharmacotherapy, the integration of state-of-the-art technologies, and the identification of novel biomarkers, all of which are transforming clinical practice. Additionally, ongoing research efforts are delving into strategies for early diagnosis, the application of personalised medicine, and the development of more effective therapeutic interventions aimed at improving clinical outcomes and enhancing the quality of life for patients with HF. 👉 Continue reading https://lnkd.in/ePHeFaKB An editorial from Patrizio Lancellotti & Arnaud ANCION 👇 ACTA subscription is included in the BSC membership 🤗 Not yet a member? Apply 👉 https://lnkd.in/eXdmShew and discover the many other benefits.

Great news

European Commission announces EU Cardiovascular Health Plan - ESC welcomes this historic milestone for fostering national and European action For more, please see https://bit.ly/41gdFJJ #CVHealthForAll

🎉Huge milestone! The EU has adopted Council conclusions on the improvement of cardiovascular health 🎉 This includes strengthening primary and secondary prevention, early detection and screening, and optimising management and rehabilitative care of CVD. The Council conclusions also call on the European Commission to ensure adequate funding and to map cardiovascular health actions in an integrated way, through primary, secondary and tertiary care. Proposed steps include promoting evidence-based prevention measures, advancing innovative treatments, and leveraging digital health tools for better data integration and research. These actions aim to reduce risk factors common to both cardiovascular diseases and cancer, such as poor nutrition, tobacco use, and physical inactivity. Read the Press Release from European Alliance for Cardiovascular Health (EACH) 👇

The BSC Congress programme includes accredited scientific and radiation sessions, a keynote lecture, joint BSC-ESC guidelines sessions, best abstracts and poster presentations, an Awards Ceremony, hands-on, satellite symposia and a scientific exhibition. Discover the programme 👉 https://lnkd.in/eAyy3CHv Register now 👉 https://lnkd.in/eApqnTAx 📆Dates : 6-7 Feb. 2025 📌Location : Brussels Expo 👇A sneak peek at our lineup👇